Houston Oncology Summit: MD Anderson’s VP of industry relations talks about partnering
Houston Oncology Summit: How the Cancer Focus Fund can help small biotechs get into phase 1 studies
Houston Oncology Summit: Talking lung cancer advances with John Heymach
Discussing the science of using transfer RNA for protein editing with hC Bioscience’s CEO
Trekk Venture Partners' Brian Gallagher gives an update on the venture market
Baird’s Brian Skorney joins BiotechTV in New York for Analyst Thursdays
Aisling Capital's Dennis Purcell gives his take on the current state of biotech
Discussing Miami as a biotech hub and general biotech sentiment with Dr. Phillip Frost
BMO Capital Markets’ Evan Seigerman joins BiotechTV for Analyst Thursdays
UPenn’s Bruce Levine discusses the progress of CAR-T at the 2023 CAR-TCR Summit
William Blair’s Matt Phipps joins BiotechTV for Analyst Thursdays
TD Cowen’s Yaron Werber joins BiotechTV for Analyst Thursdays
U.S. Representative Jake Auchincloss discusses policy issues affecting the biotech sector
BTIG’s Justin Zelin joins BiotechTV for Analyst Thursdays
Jefferies’ Michael Yee joins BiotechTV for Analyst Thursdays
In-depth analysis of the potential upcoming sickle cell gene therapy launches with ICER's president
Evercore ISI's Umer Raffat joins BiotechTV for Analyst Thursdays
Mizuho's Salim Syed joins BiotechTV for Analyst Thursdays
Citi's Neena Bitritto-Garg joins BiotechTV for Analyst Thursdays
Where Vertex Ventures HC is looking for opportunities to deploy a new $200 million fund
.png){kind=logo}
